APA (7th ed.) Citation

Y, L., Z, W., M, G., F, H., & P, C. (2026). HER3 beyond the canonical paradigm: A versatile signaling hub in oncogenesis and therapeutic resistance. Journal of translational medicine, 24(1), . https://doi.org/10.1186/s12967-026-07934-4

Chicago Style (17th ed.) Citation

Y, Li, Wang Z, Gu M, Huang F, and Chang P. "HER3 Beyond the Canonical Paradigm: A Versatile Signaling Hub in Oncogenesis and Therapeutic Resistance." Journal of Translational Medicine 24, no. 1 (2026). https://doi.org/10.1186/s12967-026-07934-4.

MLA (9th ed.) Citation

Y, Li, et al. "HER3 Beyond the Canonical Paradigm: A Versatile Signaling Hub in Oncogenesis and Therapeutic Resistance." Journal of Translational Medicine, vol. 24, no. 1, 2026, https://doi.org/10.1186/s12967-026-07934-4.